Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study

• Published in: BMC cardiovascular disorders Vol. 18; no. 1; pp. 33 - 8
• Main Authors: Chen, Ching-Yu Julius, Yang, Tzu-Ching, Chang, Christopher, Lu, Shao-Chun, Chang, Po-Yuan
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 13.02.2018; BioMed Central; BMC
• Subjects: Atherosclerosis; C-reactive protein (CRP); Care and treatment; Coronary artery disease; Heart attack; Homocysteine; Risk factors; ST-segment elevation myocardial infarction (STEMI); White blood cell (WBC); White blood cell (WBC); ST-segment elevation myocardial infarction (STEMI); C-reactive protein (CRP); Homocysteine; Coronary artery disease

Homocysteine has been long considered a risk factor for atherosclerosis. However, cardiovascular events cannot be reduced through homocysteine lowering by B vitamin supplements. Although several association studies have reported an elevation of serum homocysteine levels in cardiovascular diseases, t...